Midnight Health Ltd

Midnight Health Ltd specialises in helping innovative MedTech companies navigate the complex landscape of the NHS to introduce new products and advancements. With a focus on bringing innovative products and solutions to the NHS, our mission is to help these companies navigate the NHS, ensuring that their products are evaluated and adopted in a timely manner. We understand the importance of bridging the gap between innovative MedTech companies and the NHS, and we are dedicated to making that happen. Midnight Health provides a tailor-made approach to accessing the NHS, including market assessment and sales and marketing strategy development.

https://www.midnighthealth.co.uk



HealthTech Innovation Incubator

The HealthTech Innovation Incubator is a dedicated platform for HealthTech innovators focused on revolutionizing healthcare through technology. It offers opportunities for knowledge sharing on cutting-edge technologies, business strategies for scaling up HealthTech ventures, and networking with entrepreneurs, investors, and industry experts. Members can exchange valuable resources, receive support and mentorship, and collaborate with peers. Join us to be part of a vibrant community committed to driving innovation and shaping the future of healthcare.


Dr Jane Freeman – Early Diagnosis and Personalised Care

Jane is an Associate Professor in Clinical Microbiology at the University of Leeds and a Clinical Scientist at Leeds Teaching Hospitals Trust. She was National Clinical Lead for AMR Diagnostics at NHS England from 2022-24.

Her research interests are in Healthcare associated infections, antimicrobial resistance and infection diagnostics. She is a strong advocate for the patient voice in research and healthcare, and of women and healthcare scientists in clinical academic careers. She is Co-Chair of the Empower Leeds Women Network.


Dr Sunil Daga – Early Diagnosis and Personalised Care & Equality, Diversity and Inclusion Lead

MBBS MRCP (Nephrology) PhD @sunildaga23

Sunil is a Consultant Nephrologist at Leeds Teaching Hospitals NHS Trust and Honorary Senior Lecturer at the University of Leeds. He is the EDI lead for the NIHR HRC (Leeds) and his research interests are improving access to transplantation and improving kidney health. He has experience of working with industry on home digital technology, digital education and application of AI/ML in post transplantation outcomes.

He is an executive member of UK Organ Donation and Transplantation Research Network  and is a Subject matter expert in clinical transplant immunology. He is a Health Equity Fellow at West Yorkshire Health Inequality Network and has experience of working with several VCSE organisations across the UK in reducing health inequity. He is a strong advocate of co-production in research and wants the unheard voice to be listened in research.


Mr Ryan Mathew – Theme Lead for Minimally Invasive Therapies and Digital Technologies

Ryan Mathew is an Associate Professor at the University of Leeds and an Honorary Consultant Neurosurgeon at Leeds Teaching Hospitals. His clinical practice covers the full spectrum of general neurosurgery with a subspecialty interest in brain tumours; in particular gliomas, meningiomas and awake surgery.

After completing his PhD in Glioma Stem Cells and Organoids, and spending time at the Brain Tumour Research Centre at Sickkids in Toronto, he began co-leading the Stem Cells and Brain Tumour Lab Group where his focus is on translational approaches to technologies that deliver local therapeutic treatments.

As Neurosurgery Lead for the NIHR Surgical MedTech Cooperative, NIHR Surgical Technologies Academy Incubator and Royal College of Surgeons of England Leeds Institute of Clinical Trials Research, he also leads a research portfolio in surgical technologies and devices which encompasses virtual/mixed reality, machine learning/AI, real-time intra-operative tumour visualisation and histology, and local therapeutic delivery. He is Health Lead for Leeds XR, the Basic/Translational Science Lead for the Academic Committee of the Society of British Neurological Surgeons, member of the British Neuro-Oncology Society Research Subcommittee, a HoloMedicine Association Founding Member and Core Committee member of the Tessa Jowell Brain Cancer Mission Novel Therapeutics Accelerator.

He has published numerous papers, is an internationally invited speaker and teaching faculty, peer-reviews for a number of journals and grant award committees, and has obtained > £8M in grant funding (PI or Co-I).


Professor Tze Wah – Co-Theme Lead for Minimally Invasive Therapies and Digital Technologies

Professor Wah has been appointed at the Leeds Teaching Hospitals NHS Trust (LTHT) as Consultant in Diagnostic and Interventional Radiology since 2003 with sub-speciality interest in Interventional Oncology. She is passionate about practising evidence-based medicine and committed to the highest standards of research methodology. Since 2004, she has established, developed and leads an internationally recognised, clinical and research programme in Interventional Oncology (IO).

IO is an underrepresented clinical discipline and Professor Wah was inspired by the stories of patients that she had treated, in 2015, she led the formation of Interventional Oncology United Kingdom (IOUK) within British Society of Interventional Radiology (BSIR) to address this gap and was the founding chair for IOUK(BSIR) from 2015-2018. Subsequently, she led a cross-sectional study highlighting the lack of equity for patients to access IO services in the UK (BMJ open,2017-doi:10.1136/bmjopen-2017-016631).

In Aug 2022, University of Leeds recognised her steadfast commitment in IO clinical academia and she was appointed the first Professor of Interventional Radiology at University of Leeds, a historic achievement as the ‘UK-First’ female Professor of IO.


Professor Faisal Mushtaq – Minimally Invasive Therapies and Digital Technologies

Faisal Mushtaq is Professor of Cognitive Science and Director of the Centre for Immersive Technologies at the University of Leeds. Mushtaq’s research sits at the interface between Psychology, Engineering, and Computer Science. He is founder of the Immersive Cognition Lab which specialises in the study of learning and skill acquisition using virtual environments. He co-leads the Immersive Healthcare Collaborative, a network of scientists, clinicians and industry leaders committed to supporting the implementation of safe and effective virtual and augmented reality technologies in healthcare training and delivery.